Monday May 7 | Free Republic
Scientists Spot How Cox-2 Painkillers Raise Heart Risks
The once popular cox-2 drugs, Vioxx and Bextra, were pulled off the market in 2004 and 2005, respectively, after research showed that both raised the chances of cardiovascular trouble.
NSAIDs and Cardiovascular Risk Explained
It has been almost eight years since Vioxx was withdrawn by Merck from the market, provoking an intense controversy about the role inhibitors of the enzyme COX-2 play in causing heart attacks and strokes.
Also on Topix